1. The latest news: Merck’s Keytruda blockbuster potential in China — Spectrum pulls marketing app for Neulasta rival — Genfit seeks $132M IPO for NASH programs -- See more on our front page news

    Plus this week’s message board spotlight: Therapeutic Specialties boards
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

BioDelivery Sciences

Anonymous board for BioDelivery Sciences

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    42
    Views:
    3,217
  2. anonymous
    Replies:
    6
    Views:
    615
  3. anonymous
    Replies:
    19
    Views:
    984
  4. anonymous
    Replies:
    113
    Views:
    12,870
  5. anonymous
    Replies:
    9
    Views:
    651
  6. anonymous
    Replies:
    8
    Views:
    1,194
  7. anonymous
    Replies:
    16
    Views:
    4,323
  8. anonymous
    Replies:
    31
    Views:
    3,881
  9. anonymous
    Replies:
    5
    Views:
    1,045
  10. anonymous
    Replies:
    4
    Views:
    2,202
  11. anonymous
    Replies:
    4
    Views:
    1,418
  12. anonymous
    Replies:
    1
    Views:
    1,667
  13. anonymous
    Replies:
    6
    Views:
    3,526

Thread Display Options

Loading...

play:inline;">